NM_024509.2:c.31C>G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_024509.2(LRFN3):​c.31C>G​(p.Leu11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000934 in 1,594,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000092 ( 0 hom. )

Consequence

LRFN3
NM_024509.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.281
Variant links:
Genes affected
LRFN3 (HGNC:28370): (leucine rich repeat and fibronectin type III domain containing 3) Predicted to be involved in regulation of presynapse assembly; regulation of synaptic membrane adhesion; and synaptic membrane adhesion. Predicted to be located in plasma membrane. Predicted to be active in cell surface and glutamatergic synapse. Predicted to be integral component of postsynaptic density membrane and integral component of presynaptic active zone membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14493209).
BS2
High AC in GnomAd4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRFN3NM_024509.2 linkc.31C>G p.Leu11Val missense_variant Exon 2 of 3 ENST00000246529.4 NP_078785.1 Q9BTN0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRFN3ENST00000246529.4 linkc.31C>G p.Leu11Val missense_variant Exon 2 of 3 1 NM_024509.2 ENSP00000246529.3 Q9BTN0
LRFN3ENST00000588831.5 linkc.31C>G p.Leu11Val missense_variant Exon 3 of 4 5 ENSP00000466989.1 Q9BTN0

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000941
AC:
22
AN:
233746
Hom.:
0
AF XY:
0.0000701
AC XY:
9
AN XY:
128304
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000532
Gnomad NFE exome
AF:
0.000122
Gnomad OTH exome
AF:
0.000170
GnomAD4 exome
AF:
0.0000922
AC:
133
AN:
1442436
Hom.:
0
Cov.:
32
AF XY:
0.0000936
AC XY:
67
AN XY:
715860
show subpopulations
Gnomad4 AFR exome
AF:
0.0000601
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000631
Gnomad4 NFE exome
AF:
0.0000906
Gnomad4 OTH exome
AF:
0.0000502
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152282
Hom.:
0
Cov.:
32
AF XY:
0.0000940
AC XY:
7
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000221
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000268
Hom.:
0
Bravo
AF:
0.0000831
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.000108
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 16, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.31C>G (p.L11V) alteration is located in exon 2 (coding exon 1) of the LRFN3 gene. This alteration results from a C to G substitution at nucleotide position 31, causing the leucine (L) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.019
T;T
Eigen
Benign
0.16
Eigen_PC
Benign
0.17
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.48
.;T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.14
T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Uncertain
2.7
M;M
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.4
.;N
REVEL
Benign
0.12
Sift
Benign
0.17
.;T
Sift4G
Uncertain
0.038
D;D
Polyphen
0.90
P;P
Vest4
0.30
MVP
0.53
MPC
0.77
ClinPred
0.11
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139243712; hg19: chr19-36430358; API